Abzena Amplifies Bioconjugate Development and Manufacturing with $5 Million Bristol Site Expansion
BRISTOL, PA — Abzena has unveiled a $5 million investment to enhance its Bristol, Pennsylvania facility, specializing in bioconjugate development and cGMP (current Good Manufacturing Practice) manufacturing. This substantial financial …
Abzena Amplifies Bioconjugate Development and Manufacturing with $5 Million Bristol Site Expansion Read More